As of 2025-03-16, the EV/EBITDA ratio of G1 Therapeutics Inc (GTHX) is -11.57. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. GTHX's latest enterprise value is 406.48 mil USD. GTHX's TTM EBITDA according to its financial statements is -35.15 mil USD. Dividing these 2 quantities gives us the above GTHX EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 10.6x - 13.3x | 12.2x |
| Forward P/E multiples | 17.3x - 34.9x | 21.6x |
| Fair Price | (12.07) - (9.40) | (11.81) |
| Upside | -268.8% - -231.5% | -265.2% |
| Date | EV/EBITDA |